Clinical Trial: Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects

U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT06993181) titled 'Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects' on May 19.

Brief Summary: This study is to compare pharmacokinetics and safety profiles of DA-5222 single-administration and co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in healthy adult subjects

Study Start Date: May 22

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: DA-5222

single dose administration (DA-5222 one tablet once a day)

DRUG: DA-5222-R1 + DA-5222-R2 + DA-5222-R3

single dose administration (DA-5222-R1 one tablet once a day + DA-5222-R2...